2014 Monthly defeatHIV CAB Meetings
Clinical Studies
960x300-slider-images-2513
Publication Spotlight

defeatHIV, the Delaney Cell and Genome Engineering Initiative, is a consortium of world renowned investigators and institutions working at the forefront of curative HIV therapy research.

Our Team

Meet our dedicated team

Berlin patient

The man who inspires our work

Martin Delaney

Learn about our roots

Join Us

Help us defeatHIV



News from defeatHIV

CGT4HIVCure 2016_Dr. Hans-Peter Kiem Can immunotherapy cure HIV? Posted on August 18, 2016
DefeatHIV Logo RGB SM defeatHIV Receives Second Round of Funding from NIH Posted on July 13, 2016
CGT4HIVCure Logo Tag RGB SM Conference on Cell & Gene Therapy for HIV Cure 2016 Posted on July 12, 2016
DefeatHIV Logo RGB SM Publication Spotlight: Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates Posted on May 28, 2016

Featured

Can immunotherapy cure HIV? Posted on August 18, 2016 CGT4HIVCure 2016_Dr. Hans-Peter Kiem

Hutch News http://www.fredhutch.org/en/news/center-news/2016/08/can-immunotherapy-cure-hiv.html Can immunotherapy cure HIV? A revolution in cancer care may offer clues to a cure or remission for HIV/AIDS Aug. 8, 2016 | By Mary Engel / Fred Hutch News Service Dr. Rowena Johnston, vice president and director of research for the Foundation for AIDS Research, addresses the third annual Conference on […]

Read More